The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,701–1,800 of 1,810
Analysis of Mitochondrial DNA Mutation in Pakistani Women with Gestational Diabetes Mellitus
Khan, I., Anum, A., Khan, I., Khan, M. A., Ali, F., Khan, S., Khan, F., Jianye, Z., An, L., & Zhi-qiang, L. (2022) · International Journal of Biomedicine · doi:10.21103/article12(3)_oa17
Placental DNA methylation changes in the development of gestational diabetes mellitusPreprint
Chen, F., Li, M., Fei, X., Zhu, W., Zhang, Z., Shen, Y., Mao, Y., Zhu, Q., Xu, J., Zhou, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1375478/v2
Ojong, E. W., Nakondo, N. N., & Njouendou, A. J. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.115566
Jancsura, M. K., Grobman, W. A., Wu, J., Scifres, C., Silver, R. M., Durnwald, C. P., Post, R. J., Saade, G. A., Yee, L. M., Feghali, M. N., et al. (2025) · Nutrition · doi:10.1016/j.nut.2025.112934 · Cited by 1
“It is possible that dietary interventions aimed at type 2 diabetes may not be effective for pregnancy dysglycemia [30].”
Chen, L., Peng, D., & Xu, Y. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02956-7
“The mechanisms involve insulin resistance (IR) and insuffi - cient pancreatic beta-cell function, inflammatory responses, placental dysfunction, and gut microbiota influencing glucose metabolism [5, 6].”
Roenker, B., DuBose, K. D., Moore, E. W. G., Broskey, N. T., Whiteside, J. L., & May, L. E. (2026) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2026.09.001
Lipid metabolism profiles as predictors of gestational diabetes mellitus risk: A retrospective study
Xiu, X., Zhang, H., Lin, Y., & Yan, J. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70382
“GDM is characterized by glucose intolerance that occurs during pregnancy and can lead to serious maternal and neonatal complications 18 – 20 .”
EDUKASI EMPAT PILAR DIABETES MELLITUS KEPADA MASYARAKAT DI KELURAHAN LABUHAN DELI KEC. MEDAN MARELAN
Silaban, N. Y., & Situmorang, P. R. (2023) · Jurnal Ilmiah Pengabdian Kepada Masyarakat (Ji-SOMBA) · doi:10.52943/ji-somba.v3i1.1532 · Cited by 3
“Penatalaksanaan diabetes yang tidak tepat dapat menimbulkan berbagai komplikasi, secara umum terbagi menjadi dua jenis, yaitu komplikasi mikrovaskuler dan komplikasi makrovaskular (American Diabetes Association (ADA), 2018); (Brunner, L.S. et al., 2010), bahkan dapat berujung pada kematian.”
BackgroundSu, Y., Wei, X., Xu, F., Liu, P., Zhou, T., Zhang, X., Rao, L., & li, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4249011/v1
Bahrami, P., Movahedi, M., & Yadegari, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-9773892/v1
Oluklu, D., OLUKLU, F., SUREN, S., GENCER, A., & Onat, T. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70264 · Cited by 1
Li, L., Li, L., Shao, Y., Du, R., Shi, X., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23606867
Association between maternal multimorbidity and preterm birth: a systematic review and meta-analysis
Mastrou, L., Lamnisos, D., & Giannakou, K. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08734-w · Cited by 1
“In addition to direct biological pathways, multimorbidity increases vulnerability to pregnancy complications such as pre-eclampsia, gestational diabetes, and maternal infections, each independently linked to elevated PTB risk [ 14– 43, 46– 53].”
Zhao, Y., Wang, B., Yang, Y., & Li, H. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261474347
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Salles, O. J. D. M., & de Oliveira, G. C. M. (2026) · Research Square · doi:10.21203/rs.3.rs-11019627/v1
Nguyễn, V. H., Pham, H. M., Hoang, N. T., & Phạm, B. N. (2025) · medRxiv · doi:10.1101/2025.05.22.25328151 · Cited by 1
“However, any deficiencies in the insulin signaling process (pro-insulin synthesis, post-translational modifications, and gene alterations associated with insulin signaling) can result in β-cell dysfunction 8 .”
Study of the Levels of Immunoglobulin G and Complement 3 in Gestational Diabetes and Their Newborn
Marie, A. M., & Abid-Alkareem, I. H. (2023) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v3-i9-47
Zanardo, V., Straface, G., Volpe, F., Suppiej, A., & Battistin, T. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120609
Mazeda, M. L., Silva, B., Cidade-Rodrigues, C., Moreira, F. S., Benido-Silva, V., Gomes, V., Chaves, C., Pereira, C. A., Machado, C., Figueiredo, O., et al. (2025) · Diabetology · doi:10.3390/diabetology6100106 · Cited by 1
“GDM affects approximately 14% of pregnancies globally and is associated with neonatal and obstetric complications [1,13,14].”
InfluentialRole of nutrients in gestational diabetes management
Wani, S., Pingale, P. L., Amrutkar, S. V., & Kulkarni, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34003-1.00016-x
GlucoTwin: A Machine Learning Based Digital Twin System for Early Prediction of Gestational Diabetes
Sayed, A., Farouq, O., Adam, A. B., Mahdi, A., Talib, M. W. A., Dessì, D., Bounceur, A., Mussa, B. M., & Abusnana, S. (2026) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-032-24724-7_43
Saleem, B. N., Abdulridha, M. K., & Showman, H. A. (2024) · Journal of emergency medicine, trauma & acute care · doi:10.5339/jemtac.2024.cism.9
Liu, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21917-7.00027-6
Li, Y., Meng, Y., Mo, Y., & He, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4249882/v1
Takiso, K. T., Tsegaye, A., Mengistu, M., Woldesenbet, A., & Lemine, A. A. (2026) · Clinics · doi:10.1016/j.clinsp.2026.101160
“27,28 Recent studies also have reported that placental IGFBP1 is a potentially important regulator of insulin sensitivity during pregnancy.”
Mishra, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1949130
SAFETY AND EFFICACY OF PROTRACTED USAGE OF ORAL ANTIDIABETIC DRUGS IN TYPE-2 DIABETES MANAGEMENT
B., R., NAYEEM, N., Ashok Vardhan, N., & Durga, B. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i7.55415 · Cited by 1
Ramanathan, K., Jagadeesh, N. S., Vishwanath, U., & Dayal, C. (2022) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_8_22
Effect of High Fat and Cholesterol Diet on Total Blood Cholesterol Levels in Pregnant Wistar Rats
Desmawati, D., Mahdiyah, A. Y., & Kadri, H. (2023) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v55n1.2651 · Cited by 3
Puppi, P. E., Laguna, G. G. D. C., Moreira, R. D. C. M., & Costa, T. M. B. (2023) · doi:10.56161/sci.ed.20230900c2
คลิปสปอยล์หนังในฐานะสารนอกตัวบทและปรากฏการณ์ทางวัฒนธรรมในประเทศไทย
โคสะพละกิจ, ไ. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.652
Xia, X., & Chen, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.28.630638
Le, D.-C., Vu, T. B., Nguyen, T. L., Tran, T. N., Luong, X. H., Do, T. T. H., Tran, X. T., Nguyen, H. T. T., Ngo, V. M., Diệu, B. T. H., et al. (2024) · doi:10.2196/preprints.57467
Gök, S., Gök, B. C., Çiçek, E. A., & Şenol, H. (2026) · Medicina · doi:10.3390/medicina62091804 · Cited by 1
“Normal pregnancy requires substantial adaptation of triglyceride and lipoprotein handling, but an exaggerated response early in gestation has been linked to insulin resistance, oxidative and vascular stress, and chronic low-grade inflammation [7,8,16,17].”
Pasaribu, H. P., Andonotopo, W., Aldiansyah, D., Marpaung, J., Lubis, M. P., Barus, M. N. G., Bachnas, M. A., Prabowo, W., Yuliantara, E. E., Pramono, M. B. A., et al. (2026) · Journal of Applied Sciences and Clinical Practice · doi:10.4103/jascp.jascp_4_26
WITHDRAWN: Evaluation of Nrg4 and thiol/disulfide homeostasis in patients with GDM
CİNDOĞLU, Ç., Uyanıkoğlu, H., Esercan, A., Eren, M. A., Koyuncu, İ., & Sabuncu, T. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2023.100193
RetractedNutritional influences on gestational diabetes: A review on macronutrient and micronutrient impacts
Premnath, S. M., & Moneesh, S. (2025) · Global Journal of Health Sciences and Research · doi:10.25259/gjhsr_56_2025
Soares, G. G., Azevedo, M. D. A., de Jesus, B. M. L., Vieira, G. S., & Bristot, M. (2023) · Inova Saúde · doi:10.18616/inova.v14i3.8028 · Cited by 2
“Obesidade Grau III 11 (7,0) 1 (1,7) 4 (12,5) 5 (18,5) 0 (0,0)”
Kim, K., Choi, A., PARK, H., Kim, S.-K., & Cho, Y.-W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1901350
“GDM is characterized by a compensatory failure of insulin secretion in response to reduced insulin sensitivity during pregnancy (13).”
Jia, H., Liu, S., zhou, M., Cao, Y., Gan, X., He, P., Li, F., Xu, Y., Wang, B., & Xu, X. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08732-y
“This aligns with mechanistic evidence indicating that hepatic and adipose insulin resistance, as reflected by elevated fasting triglycerides and glucose, may precede pancreatic β-cell dysfunction and overt dysglycemia during pregnancy [35, 36].”
Wang, F., Ye, D., Ma, Y., Zhao, K., Liu, Z., & Cheng, L. (2026) · Medicine · doi:10.1097/md.0000000000048462
“[13] Early identification and intervention for GDM patients at high risk of MetS are vital for preventing long-term maternal complications and improving pregnancy outcomes.”
Li, X., Nanan, R. K. H., & Liu, A. J. W. (2026) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.70114
“Earlier studies on pathophysiology of pregnancy and diabetes have revealed that GDM can result from an increase in insulin resistance, often occurring against a background of chronic insulin resistance before pregnancy, with or without overt diabetes [6, 7].”
InfluentialAyoade, O. B., Shahrestani, S. A., & Ruan, C. (2025) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-031-97352-9_9
Lan, T., Liu, W., Li, S., Chen, S., Liu, J., Zhang, J., Heng, C., Wang, G., & Zhou, T. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120455
FAM3D levels in women with gestational diabetes
Akşit, M., Akşit, M. Z., & Alan, Y. (2022) · Minerva Forensic Medicine · doi:10.23736/s2784-8922.22.01813-1
Li, J.-Z., Chen, H., Liu, T., Tang, W., Wang, L., Wen, L., Wang, Y., Zhang, Z., Cai, Q., Zhou, N., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1571632 · Cited by 2
“Still, studies have shown that diabetes can cause insulin insuf fi ciency or resistance, which can lead to metabolic disorders of the three macronutrients (i.e., sugars, fats, and proteins) in the body, as well as abnormally high metabolic levels of protein depletion (22 – 24).”
FEATURES OF HORMONAL CHANGES DURING PUBERTY IN GIRLS BORN TO WOMEN WITH GESTATIONAL DIABETES
Mustafayeva, İ. R., Aliyeva, E. M., Asadova, S. S., Karimova, S., Abbasova, F. Y., Сафарова, С. С., & Baghirova, A. M. (2025) · World of Medicine and Biology · doi:10.26724/2079-8334-2025-2-92-121-124
Comparative analysis of inflammatory and metabolic biomarkers in PGDM and GDM pregnancies
Öçal, A., Tekin, S., Atalmış, H. A., Bafalı, İ. O., Acar, H., Kulan, P., Bilginer, C., Güleroğlu, F. Y., Öcal, E. U. B., & Cetin, A. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08597-7
“There are several types of diabetic research activities, such as insulin signaling pathways, metabolic pathways and hormonal regulation, omics studies, genetic and epigenetic factors, oxidative stress and antioxidant defense, and placental molecular changes [4].”
CONSEQUENCES OF GESTATIONAL DIABETES MELITTUS IN PREGNANT WOMEN AND FETUS: AN INTEGRATIVE REVIEW
Lorenzetti, M., Panis, L. C., Fiorello, J. R. S., da Cruz, J. R., Gödel, L., Gonçalves, E. V. M. C., Santos, D. V., de Moura, M. L. R., Zacharczuk, V. L., da Silva, L. C., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594752412084
Szablewska, A. W., & Zając, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-43352-8 · Cited by 1
Zhao, Y., Zhang, J., & Jin, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1845573
Mensah, D. O., Mensah, V. O., Mensah, P. H., AKOLOBA, L. J., Amponsah, O. C., Asare, G., & Batuu, E. (2026) · Research Square · doi:10.21203/rs.3.rs-9329607/v1
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602444
Zhang, M., Li, Q., Wang, K.-L., Dong, Y., Mu, Y.-T., Cao, Y., Liu, J., Li, Z.-H., Cui, H.-L., Liu, H.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26564004
Diboun, I., Ramanjaneya, M., Majeed, Y., Ahmed, L., Bashir, M., Butler, A. E., Abou-Samra, A. B., Atkin, S. L., Mazloum, N. A., & Elrayess, M. A. (2020) · Figshare · doi:10.6084/m9.figshare.13004324
Li, L., Li, L., Shao, Y., Du, R., Shi, X., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23606858
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721156
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721165
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602435
Cubillos, G., Monckeberg, M., Plaza, A., Morgan, M., Estévez, P. A., Choolani, M., Kemp, M. W., Illanes, S. E., & Perez, C. A. (2024) · Figshare · doi:10.6084/m9.figshare.26599286
Lu, T., Cárdenas, A., Perron, P., Hivert, M., Bouchard, L., & Greenwood, C. M. T. (2021) · Figshare · doi:10.6084/m9.figshare.14853620
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602447
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602450
Al Hashmi, I., Alsabti, H., Omari, O. A., Al Nasseri, Y., & Khalaf, A. (2022) · Figshare · doi:10.6084/m9.figshare.19643441
Lu, S., Wang, J., Kakongoma, N., Hua, W., Xu, J., Wang, Y., He, S., Gu, H., Shi, J., & Hu, W. (2022) · Figshare · doi:10.6084/m9.figshare.19860257
Li, X., Cai, Q.-Y., Luo, X., Wang, Y., Shao, L.-Z., Luo, S.-J., Wang, L., Wang, Y.-X., Lan, X., & Taihang, L. (2024) · Figshare · doi:10.6084/m9.figshare.25329660
Li, J., Li, Y., Zhou, X., Wei, L., Zhang, J., Zhu, S., Zhang, H., Gao, X., Sharifu, L. M., Wang, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14432411
Li, L., Li, L., Shao, Y., Du, R., Shi, X., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23606855
Tang, M., Luo, M., Lu, W., Zhang, R., Liang, W., Gu, J., Yu, X., Zhang, X., & Hu, C. (2020) · Figshare · doi:10.6084/m9.figshare.13265930
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721159
Zhang, C., Wang, L., Sun, W., Chen, L., Zhang, C., Li, H., Yu, J., Fan, J., Ruan, H., Zheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16436041
Lu, T., Cárdenas, A., Perron, P., Hivert, M., Bouchard, L., & Greenwood, C. M. T. (2021) · Figshare · doi:10.6084/m9.figshare.14853602
Najafi, M. L., Zarei, M., Gohari, A., Haghighi, L., Heydari, H., & Miri, M. (2020) · Figshare · doi:10.6084/m9.figshare.13357589
Li, H., Yu, X., Qiang, W., Lu, M., Jiang, M., Hou, Y., Gu, Y., Tao, F., & Zhu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19619508
Zhang, C., Wang, L., Sun, W., Chen, L., Zhang, C., Li, H., Yu, J., Fan, J., Ruan, H., Zheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16436038
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602441
Jia, Y., Jiang, H., Fu, Y., Li, Y., & Wang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26728228
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Cui, L., & Zhang, C. (2023) · Figshare · doi:10.6084/m9.figshare.22621081
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Cui, L., & Zhang, C. (2023) · Figshare · doi:10.6084/m9.figshare.22621087
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Cui, L., & Zhang, C. (2023) · Figshare · doi:10.6084/m9.figshare.22621078
Li, H., Yu, X., Qiang, W., Lu, M., Jiang, M., Hou, Y., Gu, Y., Tao, F., & Zhu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19619511
Zareei, S., Behrasi, F., Naghizadeh, M. M., Talebzadeh, F., Kharmandar, A., Farjam, M., & Homayounfar, R. (2024) · Figshare · doi:10.6084/m9.figshare.26604037
Seidkhani‐Nahal, A., Heydari, H., Tavakolian, A., Najafi, M. L., & Miri, M. (2024) · Figshare · doi:10.6084/m9.figshare.25242191
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721162
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721168
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Cui, L., & Zhang, C. (2023) · Figshare · doi:10.6084/m9.figshare.22621075
Shan, D., Wang, A., & Yi, K. (2024) · Figshare · doi:10.6084/m9.figshare.25762917
Deng, Y., Xu, C., Yang, A., Wang, Y., Peng, Y., Zhou, Y., Luo, X., Wu, Y., & Zhong, S. (2024) · Figshare · doi:10.6084/m9.figshare.26729683
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. (2022) · Figshare · doi:10.6084/m9.figshare.19602438
Salamanca-Sanabria, A., Liew, S. J., Mair, J., Iorio, M. D., Ling, Y. D. Y., Tint, M. T., Wei, Y. T., Lim, K., Ong, D., Chooi, Y. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26742641
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721174
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721171
Tang, M., Luo, M., Lu, W., Zhang, R., Liang, W., Gu, J., Yu, X., Zhang, X., & Hu, C. (2020) · Figshare · doi:10.6084/m9.figshare.13265933
Zhang, C., Wang, L., Sun, W., Chen, L., Zhang, C., Li, H., Yu, J., Fan, J., Ruan, H., Zheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16436047
Lefta, R. M., Hjazi, A., Skakodub, A. A., Dham, A., Sapaev, I. B., Khlewee, I. H., Alawadi, A. H., Alsaalamy, A., Habash, R. T., & Lari Najafi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26689133
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Cui, L., & Zhang, C. (2023) · Figshare · doi:10.6084/m9.figshare.22621084
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26721177
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.